Research tools and techniques for copper metabolism in mammals

Journal of Health Science

Volumn 57, Issue 5, 2011, Pages 385-396

  Ogra, Yasumitsu ^a  

^a SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Chaperone; Copper; Imaging; Speciation

Indexed keywords

ANTIBODY; BATHOCUPROINE SULFONATE; CHELATING AGENT; PENICILLAMINE; TETRATHIOMOLYBDIC ACID; TRIENTINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANALYTIC METHOD; CHEMICAL ANALYSIS; COPPER DEFICIENCY; COPPER METABOLISM; CYSTINURIA; DRUG BINDING; EXPERIMENTAL ANIMAL; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUNTINGTON CHOREA; IMAGING; LASER ABLATION INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; MAMMAL; MASS SPECTROMETRY; MUTANT; NANOANALYSIS; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; SCANNING X RAY FLUORESCENCE MICROSCOPY; SPECIES DIFFERENTIATION; TRANSGENIC ANIMAL; WILSON DISEASE;

ANIMALIA; MAMMALIA;

EID: 80053450369     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.57.385     Document Type: Review

References (132)

1. Kim, B. E., Nevitt, T. and Thiele, D. J. (2008) Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol., 4, 176-185.
2. Balamurugan, K. and Schaffner, W. (2006) Copper homeostasis in eukaryotes: teetering on a tightrope. Biochim. Biophys. Acta, 1763, 737-746.
3. Valko, M., Morris, H. and Cronin, M. T. (2005) Metals, toxicity and oxidative stress. Curr. Med. Chem., 12, 1161-1208.
4. Jomova, K. and Valko, M. (2011) Advances in metal-induced oxidative stress and human disease. Toxicology, 283, 65-87.
5. Nose, Y., Rees, E. M. and Thiele, D. J. (2006) Structure of the Ctr1 copper trans'PORE'ter reveals novel architecture. Trends Biochem. Sci., 31, 604-607.
6. Puig, S. and Thiele, D. J. (2002) Molecular mechanisms of copper uptake and distribution. Curr. Opin. Chem. Biol., 6, 171-180.
7. Maryon, E. B., Molloy, S. A., Zimnicka, A. M. and Kaplan, J. H. (2007) Copper entry into human cells: progress and unanswered questions. Biometals, 20, 355-364.
8. Zhou, B. and Gitschier, J. (1997) A human gene for copper uptake identified by complementation in yeast. Proc. Natl. Acad. Sci. U.S.A., 94, 7481-7486.
9. Van den Berghe, P. V., Folmer, D. E., Malingré, H. E., van Beurden, E., Klomp, A. E., van de Sluis, B., Merkx, M., Berger, R. and Klomp, L. W. (2007) Human copper transporter 2 is localized in late endo-somes and lysosomes and facilitates cellular copper uptake. Biochem. J., 407, 49-59.
10. Bertinato, J., Swist, E., Plouffe, L. J., Brooks, S. P. and L'Abbe, M. R. (2008) Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells. Biochem. J., 409, 731-740.
11. Blair, B. G., Larson, C. A., Adams, P. L., Abada, P. B., Safaei, R. and Howell, S. B. (2010) Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells. Mol. Pharmacol., 77, 912-921.
12. Gybina, A. A. and Prohaska, J. R. (2006) Variable response of selected cuproproteins in rat choroid plexus and cerebellum following perinatal copper deficiency. Genes Nutr., 1, 51-59.
13. La Fontaine, S. and Mercer, J. F. (2007) Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch. Biochem. Biophys., 463, 149-167.
14. Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R. and Cox, D. W. (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet., 5, 327-337.
15. Chelly, J., Tümer, Z., Tønnesen, T., Petterson, A., Ishikawa-Brush, Y., Tommerup, N., Horn, N. and Monaco, A. P. (1993) Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet., 3, 14-19.
16. Mercer, J. F. B., Livingston, J., Hall, B., Paynter, J. A., Begy, C., Chandrasekharappa, S., Lockhart, P., Grimes, A., Bhave, M., Siemieniak, D. and Glover, T. W. (1993) Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet., 3, 20-25.
17. Petrukhin, K., Fischer, S. G., Pirastu, M., Tanzi, R. E., Chernov, I., Devoto, M., Brzustowicz, L. M., Cayanis, E., Vitale, E., Russo, J. J., Matseoane, D., Boukhgalter, B., Wasco, W., Figus, A. L., Loudianos, J., Cao, A., Sternlieb, I., Evgrafov, I., Parano, E., Pavone, L., Warburton, D., Ott, J., Penchaszadeh, G. K., Scheinberg, I. H. and Gilliam, T. C. (1993) Mapping, cloning and genetic characterization of the region containing the Wilson disease gene. Nat. Genet., 5, 338-343.
18. Tanzi, R. E., Petrukhin, K., Chernov, I., Pellequer, J. L., Wasco, W., Ross, B., Romano, D. M., Parano, E., Pavone, L., Brzustowicz, L. M., Devoto, M., Peppercorn, J., Bush, A. I., Sternlieb, I., Pirastu, M., Gusella, J. F., Evgrafov, O., Penchaszadeh, G. K., Honig, B., Edelman, I. S., Soares, M. B., Scheinberg, I. H. and Gilliam, T. C. (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat. Genet., 5, 344-350.
19. Vulpe, C., Levinson, B., Whitney, S., Packman, S. and Gitschier, J. (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet., 3, 7-13.
20. Pufahl, R. A., Singer, C. P., Peariso, K. L., Lin, S. J., Schmidt, P. J., Fahrni, C. J., Culotta, V. C., Penner-Hahn, J. E. and O'Halloran, T. V. (1997) Metal ion chaperone function of the soluble Cu(I) receptor Atx1. Science, 278, 853-856.
21. Klomp, L. W., Lin, S. J., Yuan, D. S., Klausner, R. D., Culotta, V. C. and Gitlin, J. D. (1997) Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis. J. Biol. Chem., 272, 9221-9226.
22. Hamza, I., Schaefer, M., Klomp, L. W. and Gitlin, J. D. (1999) Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis. Proc. Natl. Acad. Sci.U.S.A., 96, 13363-13368.
23. Lutsenko, S., Barnes, N. L., Bartee, M. Y. and Dmitriev, O. Y. (2007) Function and regulation of human copper-transporting ATPases. Physiol. Rev., 87, 1011-1046.
24. Amaravadi, R., Glerum, D. M. and Tzagoloff, A. (1997) Isolation of a cDNA encoding the human homolog of COX17, a yeast gene essential for mi-tochondrial copper recruitment. Hum. Genet., 99, 329-333.
25. Glerum, D. M., Shtanko, A. and Tzagoloff, A. (1996) Characterization of COX17, a yeast gene involved in copper metabolism and assembly of cytochrome oxidase. J. Biol. Chem., 271, 14504-14509.
26. Cobine, P. A., Pierrel, F., Bestwick, M. L. and Winge, D. R. (2006) Mitochondrial matrix copper complex used in metallation of cytochrome oxi-dase and superoxide dismutase. J. Biol. Chem., 281, 36552-36559.
27. Horng, Y. C., Cobine, P. A., Maxfield, A. B., Carr, H. S. and Winge, D. R. (2004) Specific copper transfer from the Cox17 metallochaperone to both Sco1 and Cox11 in the assembly of yeast cytochrome C oxidase. J. Biol. Chem., 279, 35334-35340.
28. Culotta, V. C., Klomp, L. W., Strain, J., Casareno, R. L., Krems, B. and Gitlin, J. D. (1997) The copper chaperone for superoxide dismutase. J. Biol. Chem., 272, 23469-23472.
29. Moore, S. D., Chen, M. M. and Cox, D. W. (2000) Cloning and mapping of murine superoxide dismu-tase copper chaperone (Ccsd) and mapping of the human ortholog. Cytogenet. Cell Genet, 88, 35-37.
30. Rosenzweig, A. C. and O'Halloran, T. V. (2000) Structure and chemistry of the copper chaperone proteins. Curr. Opin. Chem. Biol., 4, 140-147.
31. Furukawa, Y., Torres, A. S. and O'Halloran, T. V. (2004) Oxygen-induced maturation of SOD1: a key role for disulfide formation by the copper chaperone CCS. EMBO J., 23, 2872-2881.
32. Lamb, A. L., Torres, A. S., O'Halloran, T. V. and Rosenzweig, A. C. (2001) Heterodimeric structure of superoxide dismutase in complex with its metal-lochaperone. Nat. Struct. Biol., 8, 751-755.
33. Wong, P. C., Waggoner, D., Subramaniam, J. R., Tessarollo, L., Bartnikas, T. B., Culotta, V. C., Price, D. L., Rothstein, J. and Gitlin, J. D. (2000) Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. U.S.A., 97, 2886-2891.
34. Tapia, L., Gonzalez-Aguero, M., Cisternas, M. F., Suazo, M., Cambiazo, V., Uauy, R. and Gonzalez, M. (2004) Metallothionein is crucial for safe intracellular copper storage and cell survival at normal and supra-physiological exposure levels. Biochem. J., 378, 617-624.
35. Ogra, Y., Aoyama, M. and Suzuki, K. T. (2006) Protective role of metallothionein against copper depletion. Arch. Biochem. Biophys., 451, 112-118.
36. Van de Sluis, B., Rothuizen, J., Pearson, P. L., van Oost, B. A. and Wijmenga, C. (2002) Identification of a new copper metabolism gene by positional cloning in a purebred dog population. Hum. Mol. Genet., 11, 165-173.
37. Narindrasorasak, S., Kulkarni, P., Deschamps, P., She, Y. M. and Sarkar, B. (2007) Characterization and copper binding properties of human COMMD1 (MURR1). Biochemistry, 46, 3116-3128.
38. Sarkar, B. and Roberts, E. A. (2011) The puzzle posed by COMMD1, a newly discovered protein binding Cu(II). Metallomics, 3, 20-27.
39. Lim, C. M., Cater, M. A., Mercer, J. F. and La Fontaine, S. (2006) Copper-dependent interaction of glutaredoxin with the N termini of the copper-ATPases (ATP7A and ATP7B) defective in Menkes and Wilson diseases. Biochem. Biophys. Res. Com-mun., 348, 428-436.
40. Lee, S. A., Fillipich, L. J. and Hyun, C. (2007) Prevalence of the exon 2 deletion of the COMMD1 gene in Australian Bedlington terriers. J. Genet., 86, 289-291.
41. Haywood, S. (2006) Copper toxicosis in Bedlington terriers. Vet. Rec., 159, 687.
42. Forman, O. P., Boursnell, M. E., Dunmore, B. J., Stendall, N., van den Sluis, B., Fretwell, N., Jones, C., Wijmenga, C., Rothuizen, J., van Oost, B. A., Holmes, N. G., Binns, M. M. and Jones, P. (2005) Characterization of the COMMD1 (MURR1) mutation causing copper toxicosis in Bedlington terriers. Anim. Genet., 36, 497-501.
43. Coronado, V. A., Bonneville, J. A., Nazer, H., Roberts, E. A. and Cox, D. W. (2005) COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology. Clin. Genet., 68, 548-551.
44. Coronado, V. A., Damaraju, D., Kohijoki, R. and Cox, D. W. (2003) New haplotypes in the Bedling-ton terrier indicate complexity in copper toxicosis. Mamm. Genome, 14, 483-491.
45. Coronado, V. A., O'Neill, B., Nanji, M. and Cox, D. W. (2008) Polymorphisms in canine ATP7B: candidate modifier of copper toxicosis in the Bedlington terrier. Vet. J., 177, 293-296.
46. Lenartowicz, M., Starzynski, R., Wieczerzak, K., Krzeptowski, W., Lipinski, P. and Styrna, J. (2011) Alterations in the expression of the Atp7a gene in the early postnatal development of the mosaic mutant mice (Atp7a mo-ms) - An animal model for Menkes disease. Gene Expr. Patterns, 11, 41-47.
47. Mercer, J. F. (1998) Menkes syndrome and animal models. Am. J. Clin. Nutr., 67, 1022S-1028S.
48. Grimes, A., Hearn, C. J., Lockhart, P., Newgreen, D. F. and Mercer, J. F. (1997) Molecular basis of the brindled mouse mutant (Mo(br)): a murine model of Menkes disease. Hum. Mol. Genet., 6, 1037-1042.
49. Mori, M. and Nishimura, M. (1997) A serine-to-proline mutation in the copper-transporting P-type ATPase gene of the macular mouse. Mamm. Genome, 8, 407-410.
50. Scheinberg, I. H. and Sternlieb, I., Eds. (1984) Wilson's disease, W. B. Saunders, Philadelphia.
51. Li, Y., Togashi, Y., Sato, S., Emoto, T., Kang, J. H., Takeichi, N., Kobayashi, H., Kojima, Y., Une, Y. and Uchino, J. (1991) Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J. Clin. Invest., 87, 1858-1861.
52. Ono, T., Abe, S. and Yoshida, M. C. (1991) Hereditary low level of plasma ceruloplasmin in LEC rats associated with spontaneous development of hepatitis and liver cancer. Jpn. J. Cancer Res., 82, 486-489.
53. Wu, J., Forbes, J. R., Chen, H. S. and Cox, D. W. (1994) The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nat. Genet., 7, 541-545.
54. Biempica, L., Rauch, H., Quintana, N. and Sternlieb, I. (1988) Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. Lab. Invest., 59, 500-508.
55. Prohaska, J. R. (1986) Genetic diseases of copper metabolism. Clin. Physiol. Biochem., 4, 87-93.
56. Theophilos, M. B., Cox, D. W. and Mercer, J. F. (1996) The toxic milk mouse is a murine model of Wilson disease. Hum. Mol. Genet., 5, 1619-1624.
57. Ludwig, J., Owen, C. A., Jr., Barham, S. S., McCall, J. T. and Hardy, R. M. (1980) The liver in the inherited copper disease of Bedlington terriers. Lab. Invest., 43, 82-87.
58. Haywood, S. and Hall, E. J. (1992) Copper toxicosis in Bedlington terriers. Vet. Rec., 131, 272.
59. Klomp, A. E., van de Sluis, B., Klomp, L. W. and Wijmenga, C. (2003) The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis. J. Hepatol., 39, 703-709.
60. Appleton, D. W. and Sarkar, B. (1971) The absence of specific copper (II)-binding site in dog albumin. A comparative study of human and dog albumins. J. Biol. Chem., 246, 5040-5046.
61. Dixon, J. W. and Sarkar, B. (1972) Absence of a specific copper(II) binding site in dog albumin is due to amino acid mutation in position 3. Biochem. Bio-phys. Res. Commun., 48, 197-200.
62. Dixon, J. W. and Sarkar, B. (1974) Isolation, amino acid sequence and copper(II)-binding properties of peptide (1-24) of dog serum albumin. J. Biol. Chem., 249, 5872-5877.
63. Van de Sluis, B., Muller, P., Duran, K., Chen, A., Groot, A. J., Klomp, L. W., Liu, P. P. and Wijmenga, C. (2007) Increased activity of hypoxia-inducible factor 1 is associated with early embryonic lethality in Commd1 null mice. Mol. Cell. Biol., 27, 4142-4156.
64. Michalska, A. E. and Choo, K. H. (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. U.S.A., 90, 8088-8092.
65. Kondo, Y., Yanagiya, T., Himeno, S., Yamabe, Y., Schwartz, D., Akimoto, M., Lazo, J. S. and Imura, N. (1999) Simian virus 40-transformed metalloth-ionein null cells showed increased sensitivity to cadmium but not to zinc, copper, mercury or nickel. Life Sci., 64, PL145-PL150.
66. Kelly, E. J. and Palmiter, R. D. (1996) A murine model of Menkes disease reveals a physiological function of metallothionein. Nat. Genet., 13, 219-222.
67. Kuo, Y. M., Zhou, B., Cosco, D. and Gitschier, J. (2001) The copper transporter CTR1 provides an es sential function in mammalian embryonic development. Proc. Natl. Acad. Sci. U.S.A., 98, 6836-6841.
68. Lee, J., Prohaska, J. R. and Thiele, D. J. (2001) Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc. Natl. Acad. Sci. U.S.A., 98, 6842-6847.
69. Nose, Y., Kim, B. E. and Thiele, D. J. (2006) Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metab., 4, 235-244.
70. Nose, Y., Wood, L. K., Kim, B. E., Prohaska, J. R., Fry, R. S., Spears, J. W. and Thiele, D. J. (2010) Ctr1 is an apical copper transporter in mammalian intestinal epithelial cells in vivo that is controlled at the level of protein stability. J. Biol. Chem., 285, 32385-32392.
71. Lee, J., Pena, M. M., Nose, Y. and Thiele, D. J. (2002) Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem., 277, 4380- 4387.
72. Hamza, I., Faisst, A., Prohaska, J., Chen, J., Gruss, P. and Gitlin, J. D. (2001) The metallochaperone Atox1 plays a critical role in perinatal copper home-ostasis. Proc. Natl. Acad. Sci. U.S.A., 98, 6848- 6852.
73. Hamza, I., Prohaska, J. and Gitlin, J. D. (2003) Essential role for Atox1 in the copper-mediated in-tracellular trafficking of the Menkes ATPase. Proc. Natl. Acad. Sci. U.S.A., 100, 1215-1220.
74. Takahashi, Y., Kako, K., Kashiwabara, S., Takehara, A., Inada, Y., Arai, H., Nakada, K., Kodama, H., Hayashi, J., Baba, T. and Munekata, E. (2002) Mammalian copper chaperone Cox17p has an essential role in activation of cytochrome C oxidase and embryonic development. Mol. Cell. Biol., 22, 7614-7621.
75. Eisses, J. F. and Kaplan, J. H. (2000) Molecular characterization of hCTR1, the human copper uptake protein. J. Biol. Chem., 277, 29162-29171.
76. Linz, R., Barnes, N. L., Zimnicka, A. M., Kaplan, J. H., Eipper, B. A. and Lutsenko, S. (2008) Intracellu-lar targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/-kidney. Am. J. Physiol. Renal Physiol., 294, 53-61.
77. Bartee, M. Y. and Lutsenko, S. (2007) Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level. Biometals, 20, 627-637.
78. Heaton, D., Nittis, T., Srinivasan, C. and Winge, D. R. (2000) Mutational analysis of the mitochondrial copper metallochaperone Cox17. J. Biol. Chem., 275, 37582-37587.
79. Miyayama, T., Ishizuka, Y., Iijima, T., Hiraoka, D. and Ogra, Y. (2011) Roles of copper chaperone for superoxide dismutase 1 and metallothionein in copper homeostasis. Metallomics, 3, 693-701.
80. Wilson, E. W., Jr. and Martin, R. B. (1971) Penicil-lamine deprotonations and interactions with copper ions. Arch. Biochem. Biophys., 142, 445-454.
81. Grand, R. J. and Vawter, G. F. (1975) Juvenile Wilson disease: histologic and functional studies during penicillamine therapy. J. Pediatr., 87, 1161-1170.
82. Wright, J. R. and Frieden, E. (1975) Properties of the red-violet complex of copper and penicil-lamine and further insight into its formation reaction. Bioinorg. Chem., 4, 163-175.
83. Arnon, R., Calderon, J. F., Schilsky, M., Emre, S. and Shneider, B. L. (2007) Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment. J. Pediatr. Gastroenterol. Nutr., 44, 596-602.
84. Nagano, S., Ogawa, Y., Yanagihara, T. and Sakoda, S. (1999) Benefit of a combined treatment with tri-entine and ascorbate in familial amyotrophic lateral sclerosis model mice. Neurosci. Lett., 265, 159-162.
85. Taylor, R. M., Chen, Y. and Dhawan, A. (2009) Triethylene tetramine dihydrochloride (trientine) in children with Wilson disease: experience at King's College Hospital and review of the literature. Eur. J. Pediatr., 168, 1061-1068.
86. Kodama, H. and Fujisawa, F. (2009) Copper metabolism and inherited coppertransport disorders: molecular mechanisms, screening, and treatment. Metallomics, 1, 42-52.
87. Brewer, G. J., Johnson, V., Dick, R. D., Kluin, K. J., Fink, J. K. and Brunberg, J. A. (1996) Treatment of Wilson disease with ammonium tetrathiomolyb-date. II. Initial therapy in 33 neurologically affected patients and follow-up with zinc therapy. Arch. Neu-ro l., 53, 1017-1025.
88. Brewer, G. J., Askari, F., Dick, R. B., Sitterly, J., Fink, J. K., Carlson, M., Kluin, K. J. and Lorincz, M. T. (2009) Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Transl. Res., 154, 70-77.
89. Brewer, G. J., Askari, F., Lorincz, M. T., Carlson, M., Schilsky, M., Kluin, K. J., Hedera, P., Moretti, P., Fink, J. K., Tankanow, R., Dick, R. B. and Sitterly, J. (2006) Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch. Neurol., 63, 521-527.
90. Brewer, G. J., Dick, R. D., Johnson, V., Wang, Y., Yuzbasiyan-Gurkan, V., Kluin, K., Fink, J. K. and Aisen, A. (1994) Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. Arch. Neurol., 51, 545-554.
91. Brewer, G. J. (2009) Zinc and tetrathiomolybdatefor the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases. Metallomics, 1, 199-206.
92. Ogra, Y., Komada, Y. and Suzuki, K. T. (1999) Comparative mechanism and toxicity of tetra- and dithiomolybdates in the removal of copper. J. Inorg. Biochem., 75, 199-204.
93. Ogra, Y., Ohmichi, M. and Suzuki, K. T. (1995) Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats. J. Trace Elem. Med. Biol., 9, 165-169.
94. Ogra, Y., Ohmichi, M. and Suzuki, K. T. (1996) Mechanisms of selective copper removal by tetrathiomolybdate from metallothionein in LEC rat. Toxicology, 106, 75-83.
95. Ogra, Y. and Suzuki, K. T. (1995) Removal and efflux of copper from Cu-metallothionein as Cu/tetrathiomolybdate complex in LEC rats. Res. Commun. Mol. Pathol. Pharmacol., 88, 196-204.
96. Ogra, Y., Suzuki, K. T. (1998) Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats. J. Inorg. Biochem., 70, 49-55.
97. Ogra, Y., Chikusa, H. and Suzuki, K. T. (2000) Metabolic fate of the insoluble copper/ tetrathiomolybdate complex formed in the liver of LEC rats with excess tetrathiomolybdate. J. Inorg. Biochem., 78, 123-128.
98. Ogra, Y., Miyayama, T. and Anan, Y. (2010) Effect of glutathione depletion on removal of copper from LEC rat livers by tetrathiomolybdate. J. Inorg. Biochem., 104, 858-862.
99. Tallaksen-Greene, S. J., Janiszewska, A., Benton, K., Hou, G., Dick, R., Brewer, G. J. and Albin, R. L. (2009) Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease. Neurosci. Lett., 452, 60-62.
100. Coloso, R. M., Drake, M. R. and Stipanuk, M. H. (1990) Effect of bathocuproine disulfonate, a copper chelator, on cyst(e)ine metabolism by freshly isolated rat hepatocytes. Am. J. Physiol., 259, E443- E450.
101. Mohindru, A., Fisher, J. M. and Rabinovitz, M. (1983) Bathocuproine sulphonate: a tissue culture-compatible indicator of copper-mediated toxicity. Nature, 303, 64-65.
102. Cherny, R. A., Barnham, K. J., Lynch, T., Volitakis, I., Li, Q. X., McLean, C. A., Multhaup, G., Beyreuther, K., Tanzi, R. E., Masters, C. L. and Bush, A. I. (2000) Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease. J. Struct. Biol., 130, 209-216.
103. Templeton, D., Ariese, F., Cornelis, R., Danielsson, L. G., Muntau, H., van Leeuven, H. P. and Lobinski, R. (2000) Guidelines for terms related to chemical speciation and fractionation of elements. Definitions, structural aspects, and methodological approaches. Pure Appl. Chem., 72, 1453-1470.
104. Szpunar, J. (2005) Advances in analytical methodology for bioinorganic speciation analysis: metal-lomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics. Analyst, 130, 442- 465.
105. Szpunar, J. and Lobinski, R. (2003) Hyphenated Techniques in Speciation Analysis, The Royal Society of Chemistry, Cambridge.
106. Hirschfeld, T. (1980) The hy-phen-ated methods. Anal. Chem., 52, 297A-312A.
107. Inagaki, K., Mikuriya, N., Morita, S., Haraguchi, H., Nakahara, Y., Hattori, M., Kinosita, T. and Saito, H. (2000) Speciation of protein-binding zinc and copper in human blood serum by chelating resin pre-treatment and inductively coupled plasma mass spectrometry. Analyst, 125, 197-203.
108. Mestek, O., Kominkova, J., Koplik, R., Zima, T., Miskusova, M. and Stern, P. (2002) Speciation of Cu, Se, Zn and Fe in blood serum of hemodialysed patients. Sb. Lek., 103, 23-27.
109. Van Campenhout, K., Infante, H. G., Adams, F. and Blust, R. (2004) Induction and binding of Cd, Cu, and Zn to metallothionein in carp (Cyprinus carpio) using HPLC-ICP-TOFMS. Toxicol. Sci., 80, 276-287.
110. Wuilloud, R. G., Kannamkumarath, S. S. and Caruso, J. A. (2004) Speciation of nickel, copper, zinc, and manganese in different edible nuts: a comparative study of molecular size distribution by SEC-UV-ICP-MS. Anal. Bioanal. Chem., 379, 495-503.
111. Suzuki, K. T. (1995) Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein. Res. Commun. Mol. Pathol. Pharmacol., 89, 221-240.
112. Suzuki, K. T., Kanno, S., Misawa, S. and Aoki, Y. (1995) Copper metabolism leading to and following acute hepatitis in LEC rats. Toxicology, 97, 81-92.
113. Suzuki, K. T., Kanno, S., Misawa, S. and Sumi, Y. (1993) Changes in copper distribution in the plasma and kidneys of LEC rats following acute hepatitis. Res. Commun. Chem. Pathol. Pharmacol., 82, 225-232.
114. Suzuki, K. T., Kanno, S., Misawa, S. and Sumi, Y. (1993) Changes in hepatic copper distribution leading to hepatitis in LEC rats. Res. Commun. Chem. Pathol. Pharmacol., 82, 217-224.
115. Schaumloeffel, D., Ruiz Encinar, J. and Lobinski, R. (2003) Development of a sheathless interface between reversed-phase capillary HPLC and ICPMS via a microflow total consumption nebulizer for se-lenopeptide mapping. Anal. Chem., 75, 6837-6842.
116. Ogra, Y., Ishiwata, K., Ruiz Encinar, J., Lobinski, R. and Suzuki, K. T. (2004) Speciation of selenium in selenium-enriched shiitake mushroom, Lentinula edodes. Anal. Bioanal. Chem., 379, 861-866.
117. Miyayama, T., Ogra, Y. and Suzuki, K. T. (2007) Separation of metallothionein isoforms extracted from isoform-specific knockdown cells on two-dimensional micro high-performance liquid chro-matography hyphenated with inductively coupled plasma-mass spectrometry. J. Anal. At. Spectrom., 22, 179-182.
118. Miyayama, T., Ogra, Y., Osima, Y. and Suzuki, K. T. (2008) Narrow bore HPLC-ICP-MS for specia-tion of copper in mutant mouse neonates bearing a defect in Cu metabolism. Anal. Bioanal. Chem., 390, 1799-1804.
119. Becker, J. S. and Jakubowski, N. (2009) The synergy of elemental and biomolecular mass spec-trometry: new analytical strategies in life sciences. Chem. Soc. Rev., 38, 1969-1983.
120. Becker, J. S., Matusch, A., Palm, C., Salber, D. and Morton, K. A. (2010) Bioimaging of metals in brain tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and metallomics. Metallomics, 2, 104-111.
121. Becker, J. S., Zoriy, M., Matusch, A., Wu, B., Salber, D. and Palm, C. (2010) Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). Mass Spectrom. Rev., 29, 156-175.
122. Fahrni, C. J. (2007) Biological applications of X-ray fluorescence microscopy: exploring the subcel-lular topography and speciation of transition metals. Curr. Opin. Chem. Biol., 11, 121-127.
123. McRae, R., Bagchi, P., Sumalekshmy, S. and Fahrni, C. J. (2009) In situ imaging of metals in cells and tissues. Chem. Rev., 109, 4780-4827.
124. Boxer, S. G., Kraft, M. L. and Weber, P. K. (2009) Advances in imaging secondary ion mass spectrom-etry for biological samples. Annu. Rev. Biophys., 38, 53-74.
125. Wang, L. M., Becker, J. S., Wu, Q., Oliveira, M. F., Bozza, F. A., Schwager, A. L., Hoffman, J. M. and Morton, K. A. (2010) Bioimaging of copper alterations in the aging mouse brain by autoradio-graphy, laser ablation inductively coupled plasma mass spectrometry and immunohistochemistry.Met-allomics, 2, 348-353.
126. McRae, R., Lai, B. and Fahrni, C. J. (2010) Copper redistribution in Atox1-deficient mouse fibrob-last cells. J. Biol. Inorg. Chem., 15, 99-105.
127. Yang, L., McRae, R., Henary, M. M., Patel, R., Lai, B., Vogt, S. and Fahrni, C. J. (2005) Imaging of the intracellular topography of copper with a fluorescent sensor and by synchrotron x-ray fluorescence microscopy. Proc. Natl. Acad. Sci. U.S.A., 102, 11179-11184.
128. Zeng, L., Miller, E. W., Pralle, A., Isacoff, E. Y. and Chang, C. J. (2006) A selective turn-on fluorescent sensor for imaging copper in living cells. J. Am. Chem. Soc., 128, 10-11.
129. Miller, E. W., Zeng, L., Domaille, D. W. and Chang, C. J. (2006) Preparation and use of Coppersensor-1, a synthetic fluorophore for live-cell copper imaging. Nat. Protoc., 1, 824-827.
130. Miyayama, T., Hiraoka, D., Kawaji, F., Nakamura, E., Suzuki, N. and Ogra, Y. (2010) Roles of COMM-domain-containing 1 in stability and recruitment of the copper-transporting ATPase in a mouse hep-atoma cell line. Biochem. J., 429, 53-61.
131. Miyayama, T., Suzuki, K. T. and Ogra, Y. (2009) Copper accumulation and compartmentalization in mouse fibroblast lacking metallothionein and copper chaperone, Atox1. Toxicol. Appl. Pharmacol., 237, 205-213.
132. Domaille, D. W., Zeng, L. and Chang, C. J. (2010) Visualizing ascorbate-triggered release of labile copper within living cells using a ratiometric fluorescent sensor. J. Am. Chem. Soc., 132, 1194-1195.